Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 3
March 2024
Volume 65, Issue 3
Open Access
Clinical and Epidemiologic Research  |   March 2024
Longitudinal Changes in Choroidal Thickness Varied With Refractive Progression in Myopic and Non-Myopic Children: A Two-Year Cohort Study
Author Affiliations & Notes
  • Menglu Shen
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
    Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China
  • Xiaotong Han
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
    Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China
  • Yan Yang
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
    Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China
  • Hailu Huang
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
    Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China
  • Jinen Hou
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
    Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China
  • Ling Jin
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
    Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China
  • Xinping Yu
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
    Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China
  • Yangfa Zeng
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
    Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China
  • Mingguang He
    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, Guangdong, China
    Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China
    Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia
    Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia
  • Correspondence: Xinping Yu, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, No. 54, Xianlie South Road, Guangzhou, Guangdong Province 510062, China; [email protected]
  • Yangfa Zeng, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, No. 54, Xianlie South Road, Guangzhou, Guangdong Province 510062, China; [email protected]
  • Footnotes
     MS and XH are joint first authors.
Investigative Ophthalmology & Visual Science March 2024, Vol.65, 17. doi:https://doi.org/10.1167/iovs.65.3.17
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Menglu Shen, Xiaotong Han, Yan Yang, Hailu Huang, Jinen Hou, Ling Jin, Xinping Yu, Yangfa Zeng, Mingguang He; Longitudinal Changes in Choroidal Thickness Varied With Refractive Progression in Myopic and Non-Myopic Children: A Two-Year Cohort Study. Invest. Ophthalmol. Vis. Sci. 2024;65(3):17. https://doi.org/10.1167/iovs.65.3.17.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate the longitudinal changes in subfoveal choroidal thickness (SFCT) in children with different refractive status.

Methods: A total of 2290 children 3 to 14 years old who attended the first year of kindergarten (G0), first year of primary school (G1), fourth year of primary school (G4), or first year of junior high school (G7) in Guangzhou, China, were recruited and followed up for 2 years. All participants received cycloplegic autorefraction, axial length measurement and SFCT measurement using a CIRRUS HD-OCT device. Children were divided into groups of persistent non-myopia (PNM), persistent myopia (PM), or newly developed myopia (NDM). Children in the PNM and PM groups were further divided into subgroups of stable refraction (absolute mean annual spherical equivalent refraction [SER] change < 0.5 D) and refractive progression (absolute mean annual SER change ≥ 0.5 D).

Results: The mean ± SD ages for the G1 to G7 cohorts were 3.89 ± 0.30, 6.79 ± 0.47, 9.71 ± 0.34, and 12.54 ± 0.38, years, respectively. SFCT consistently decreased in the NDM group across the G1 to G7 cohorts (all P < 0.001) and exhibited variability across different age cohorts in the PNM and PM groups. Further subgroup analysis revealed significant thickening of SFCT in the PNM-stable group among the G0, G1, and G7 cohorts (all P < 0.05), whereas it remained stable among all cohorts in the PM-stable group (all P > 0.05). Conversely, SFCT exhibited thinning in the G4 and G7 cohorts in the PM-progressive group (both P < 0.01) and for the entire cohort of children in the PNM-progressive group (P = 0.012).

Conclusions: SFCT increased in nonmyopic children with stable refraction, remained stable in myopic children maintained stable refraction, and decreased in those with refractive progression, whether they were myopic or not.

The recent surging prevalence of myopia globally has raised significant concerns, particularly in Asian countries.13 Although the physiologic mechanisms of myopia remain unclear, increasing attention has been focused on the role of the choroid in the processes of emmetropization and myopization.4 Located in the middle layer of the eye wall, the choroid is sensitive to retinal defocus signals and thins in response to hyperopic defocus, which is considered a risk factor for myopia.57 Furthermore, the choroid may also play a role in the modulation of scleral growth by synthesizing signaling molecules or regulating blood perfusion.4,8 Choroidal thickness (ChT) is closely related to eye length and typically decreases with axial elongation. Generally, non-myopic children have thicker choroids than their myopic counterparts.9,10 
Another key factor influencing ChT is age. Previous animal studies on the natural rhythm of choroidal growth have suggested that the choroid thickens from infancy to maturity in primates reared with unrestricted vision.11,12 However, the process of choroidal change in human eyes remains uncertain. Existing studies have yielded conflicting results. Cross-sectional observations on ChT typically show thickening with age among children from Western countries10,13 and thinning with age among Asian children.14,15 This inconsistency extends to longitudinal observations when considering myopia. ChT was reported to increase,9,16 remain unchanged,17 or decrease18 in nonmyopic eyes and to increase slightly9 or decrease16,19 in myopic eyes during follow-up. Given that age and myopia both affect ChT in children, the selection of age range and myopic proportion significantly influences the study of intrinsic choroidal changes. Consequently, the purposes of this study were to investigate the longitudinal changes in ChT among children with varying degrees of myopia progression. 
Methods
Study Population
This research was conducted as part of the Zengcheng School Myopia Study (ZOOM).20,21 Briefly, 7050 children in four different grades (first-year kindergarten, grade 0 [G0]; first-year primary school, grade 1 [G1]; fourth-year primary school, grade 4 [G4]; and first-year junior high school, grade 7 [G7]) were recruited from Guangzhou, China. Ocular examinations were performed on all participating children. Due to time constraints in the mass screening programs implemented within schools, the evaluation of subfoveal choroidal thickness (SFCT) was conducted on 3554 children from these four grades using stratification sampling. Written informed consent was obtained from all children and their parents or guardians before each visit. This study was conducted according to the tenets of the Declaration of Helsinki and has been registered on clinicaltrial.gov (NCT03589937). This study was approved by the Institutional Review Board of Zhongshan Ophthalmic Center, Guangzhou, China (2018KYPJ079). 
Among the 3554 participants involved in the SFCT measurements within the ZOOM study, children exhibiting the following conditions were excluded from the current research: (1) absence of baseline or follow-up ocular assessments; (2) best-corrected visual acuity (BCVA) below 20/40 for children ages 3 to 5 years and below 20/25 for those 6 years and older; (3) history of systemic abnormalities or ocular diseases (e.g., amblyopia, strabismus, cataract, glaucoma, retinal disease); (4) prior exposure to atropine eye drops, orthokeratology treatment, myopia control spectacles, or multifocal soft contact lenses during both baseline and follow-up; (5) poor choroidal imaging quality; or (6) inadequate follow-up optical coherence tomography (OCT) data. Basic information on sex, age, and grade was recorded. Ocular examinations and OCT measurements were primarily conducted in the months of October and November, with a few instances in December, both during the baseline assessment in 2018 and throughout the subsequent follow-ups in 2019 and 2020. All OCT data were consistently collected between 10 AM and 4 PM. At each follow-up visit, all participants underwent examination using the same equipment and protocol as in the baseline measurement. 
Ocular Examinations
Ocular examinations including BCVA, refractive error, slit-lamp examination, and axial length (AL) measurements were performed. The BCVA was measured at a distance of 5 meters using an Early Treatment Diabetic Retinopathy Study chart with optimal correction. AL was measured using swept-source OCT-based biometry (ZEISS IOLMaster 700; Carl Zeiss Meditec, Oberkochen, Germany) before cycloplegia. Five readings with the lowest standard deviation (SD), not exceeding 0.1 mm, were averaged and recorded for each eye. Three drops of 1% cyclopentolate hydrochloride (Alcon, Fort Worth, TX, USA) were used to induce cycloplegia, with one drop being administered at 0, 5, and 25 minutes.22 Successful cycloplegia was achieved when the pupil diameter was at least 6 mm and the pupillary light reflex was absent. Otherwise, an additional drop of cyclopentolate was administered and cycloplegic status was re-examined 20 minutes later. Cycloplegic autorefraction was examined using a close-field autorefractor with measurement accuracy of 0.12 diopter (D) for power and 1° for axis (KR-8800; Topcon, Tokyo, Japan). 
Measurement of Choroidal Thickness
The OCT analysis of SFCT was conducted on the right eye after cycloplegia using a CIRRUS HD-OCT device (Carl Zeiss Meditec) with a transverse resolution of 15 µm and an axial resolution of 5 µm. Both a 512 × 128 macular cube protocol and high-definition (HD) radial macular scan were performed for all participants. The HD radial macular scan, comprised of 12 radial lines separated by 15° and covering a 6-mm-diameter circular area centered on the fovea, was utilized for choroidal imaging, along with an enhanced depth imaging modality (Fig. 1 Left). Each radial line scan included 1024 A-scans and was averaged by eight B-scans. The automatic eye-tracking feature was employed during OCT scanning, and the follow-up function was used for all participants at every follow-up scan. The fovea was defined as the thinnest central point of the macular. The SFCT was defined as the perpendicular distance between the Bruch membrane and the choroid–scleral interface at the fovea (Fig. 1 Right). The horizontal section of the HD radial macular scan was chosen for further manual measurement of SFCT using the built-in linear measurement tool. Each image was evaluated by two independent technicians, and their measurements of SFCT were averaged and included in the final analysis. Images with signal strengths of less than 7, motion artifacts, foveal misalignment, or unclear choroidoscleral boundaries were excluded. A total of 50 images were randomly selected to test the interrater reliability and within-rater repeatability of SFCT measurements before formal measuring. The mean interrater difference was −1.68 µm (95% confidence interval [CI], −7.59 to 4.23), with 96% of the measurement points located inside the 95% limits of agreement (LoA), indicating good interrater reliability. The mean within-rater difference was −0.68 µm (95% CI, −8.16 to 6.80), with 98% of measurement points falling within the 95% LoA, indicating strong within-rater reliability (Supplementary Figs. S1, S2). 
Statistical Analysis
Only data from the right eyes were analyzed. The longitudinal changes in the acquired parameters during the 2-year follow-up were calculated as annual average changes. Myopia was defined as a cycloplegic spherical equivalent refraction (SER) ≤ −0.50 D. Children were divided into three different refractive status groups: persistent non-myopia (PNM; SER > −0.5 D at baseline and during follow-up), persistent myopia (PM; SER ≤ −0.5 D at baseline and during follow-up), or newly developed myopia (NDM; SER > −0.5 D at baseline and ≤ −0.5 D during follow-up). Given that children in the PNM or PM groups still exhibited different rates of SER progression, they were further categorized into stable (absolute mean annual SER change < 0.5 D) or progressive (absolute mean annual SER change ≥ 0.5 D) subgroups. 
Continuous data are presented as mean ± SD or as median (interquartile range [IQR]), and their normality was tested using the Kolmogorov‒Smirnov test. Categorical data were presented as absolute and relative frequencies. The baseline distributions among the three refractive status groups were compared by the  χ2 test, ANOVA, or Kruskal–Wallis test. Tests for linear trend were performed for annual changes in SER, AL, and SFCT among the three refractive status groups. Student’s t-test or Mann‒Whitney U test was used to compare the differences between the stable and progressive groups. Additionally, differences between baseline and follow-up data were compared using either the paired t-test or Wilcoxon signed-rank test. The locally weighted scatterplot smoothing (LOWESS) plots were constructed to show the changes in SFCT with AL growth in both the PNM and PM groups. Linear regression models were fitted to assess potential factors associated with SFCT in different refractive status groups. The LOWESS regression was performed using RStudio 1.3.1093 (R Foundation for Statistical Computing, Vienna, Austria). Statistical analysis was performed using SPSS Statistics 24.0 (IBM, Chicago, IL, USA). A two-sided P value < 0.05 was considered statistically significant. The P values for multiple comparisons were adjusted using the Bonferroni adjustment method. 
Results
Of the 3554 children involved in baseline OCT measurements, 20 were excluded due to poor BCVA; 836 were excluded for missing follow-up OCT data or initiation of interventions such as atropine, orthokeratology, myopia control spectacles, or multifocal soft contact lenses during the follow-up period; 336 were excluded due to poor signal strength in OCT imaging or unrecognized choroidoscleral boundaries; and 72 were excluded due to missing baseline or follow-up ocular parameters. Finally, data from 2290 children were included in the final analysis. The distribution of age, gender, and SER was comparable among the four age groups between the final sample and the baseline sample (Supplementary Table S1). Baseline and follow-up characteristics of children excluded due to image quality issues are outlined in Supplementary Table S2. Notably, no significant differences in SER or AL were found between the excluded and final samples in the G0 and G1 cohorts. However, children excluded in the G4 (n = 93) and G7 (n = 81) cohorts exhibited more hyperopia in SER: G4 baseline, 0.46 ± 1.36 D versus 0.50 D (IQR, −0.50 to 0.88; P = 0.027); G4 follow-up, −0.27 ± 1.69 D versus −0.63 D (IQR, −2.25 to 0.38; P = 0.001); G7 baseline: −0.13 D (IQR, −1.57 to 0.50) versus −0.75 D (IQR, −2.38 to 0.38; P = 0.028); G7 follow-up: −1.21 ± 1.98 D versus −1.79 ± 2.12 D (P = 0.038). Furthermore, excluded children in the G4 cohort had a significantly shorter AL (baseline: 23.27 ± 0.98 vs. 23.53 ± 0.80 mm, P = 0.019; follow-up: 23.76 ± 1.12 vs. 24.13 ± 0.90 mm, P = 0.004). 
The baseline characteristics of the study participants are shown in Table 1. The mean ± SD ages of children were 3.89 ± 0.30 years in the G0 cohort, 6.79 ± 0.47 years in the G1 cohort, 9.71 ± 0.34 years in the G4 cohort, and 12.54 ± 0.38 years in the G7 cohort. The number of children classified into the PNM, PM, or NDM groups was 1543, 476, and 271, respectively. Within each refractive group, sex distribution was comparable across different age cohorts (all P > 0.05, data not tabulated). Additionally, there was a decreasing trend in SER and an increasing trend in AL with age across different age cohorts (all P < 0.05, data not tabulated). In terms of variations among subgroups, children in the PNM group had the thickest SFCT, followed by the NDM and PM groups in G4 and G7 (both P < 0.001). No significant differences were observed for SFCT distribution among the three groups in G1 (P = 0.253). The distributions of SER and AL were significantly different among the PNM, NDM, and PM groups in G1, G4, and G7 (all P < 0.001). 
Table 1.
 
Baseline Characteristics of the Study Participants
Table 1.
 
Baseline Characteristics of the Study Participants
The mean annual changes of SER, AL, and SFCT for children with PNM, PM, or NDM in each cohort are shown in Table 2. Among the G1 to G7 groups, children in the NDM group demonstrated the fastest progression rate in both SER and AL changes, followed by those in the PM and PNM groups (all P < 0.001). With regard to the changes in SFCT, children in the PNM group exhibited close-to-significant SFCT thickening in G0 (P = 0.055) and significant thickening in G1 and G7 (both P < 0.001). Children in the NDM group, in contrast, had consistent SFCT thinning from G1 to G7 (all P < 0.001). SFCT thinned in G4 (P < 0.001) and remained unchanged in G1 and G7 (both P > 0.05) in the PM group. AL growth was consistently negatively correlated with SFCT changes across age groups and refractive groups (all P < 0.05). 
Table 2.
 
Baseline and Follow-Up Characteristics of SER, AL, and SFCT in Three Refractive Groups
Table 2.
 
Baseline and Follow-Up Characteristics of SER, AL, and SFCT in Three Refractive Groups
Table 3 and Figure 2 show the mean annual changes in AL, SER, and SFCT for children with stable or progressive SER. AL increased and SER myopic shifted in all four subgroups, with the PM-progressive group having the largest magnitude, followed by the PNM-progressive, PM-stable, and PNM-stable groups (P < 0.001). The increase in AL was consistently larger in the G4 cohort across all refractive groups compared with children in G7 (all P < 0.05, data not tabulated). For SFCT, significant thickening was observed in the PNM-stable group in the G0, G1, and G7 cohorts (all P < 0.05), but not in the G4 cohort (P = 0.407). SFCT changes were comparable between boys and girls from G0 to G4, except in G7, where a larger thickening was observed in boys (P = 0.017, data not tabulated). In the PM-stable group, SFCT variations were not significant from G1 to G7 (all P > 0.05). The average rate of SFCT thickening was significantly faster in the PNM-stable group, measuring 4.54 ± 19.07 µm/y, compared to 1.22 ± 16.08 µm/y in the PM-stable group among all children overall (P = 0.006). The two progressive groups showed a close-to-significant decrease in SFCT in G4 in PNM children and a significant decrease in G4 and G7 in PM children. Additionally, the decrease of SFCT was larger in PM-progressive girls in the G7 cohort (P = 0.024, data not tabulated). The rate of SFCT thinning was comparable between two progressive groups among children overall (−6.59 ± 23.17 vs. −6.92 ± 16.41 µm/y; P = 0.907), as well as within the G4 cohort (−8.86 ± 23.07 vs. −9.53 ± 14.65 µm/y; P = 0.884). 
Table 3.
 
Baseline and Follow-Up Characteristics in SER, AL, and SFCT Among Children With Different Rates of SER Progression
Table 3.
 
Baseline and Follow-Up Characteristics in SER, AL, and SFCT Among Children With Different Rates of SER Progression
Figure 1.
 
(Left) An example of the HD radial macular scan using the CIRRUS HD-OCT device. (Right) Illustration of choroidal thickness measurement at the fovea; a perpendicular line was drawn from the posterior edge of the retinal pigment epithelium to the choroid–sclera junction using the built-in caliper tool.
Figure 1.
 
(Left) An example of the HD radial macular scan using the CIRRUS HD-OCT device. (Right) Illustration of choroidal thickness measurement at the fovea; a perpendicular line was drawn from the posterior edge of the retinal pigment epithelium to the choroid–sclera junction using the built-in caliper tool.
Figure 2.
 
Mean annual changes in AL (A) and SFCT (B) across different age cohorts among children within the PNM-stable, PM-stable, PNM-progressive, and PM-progressive groups.
Figure 2.
 
Mean annual changes in AL (A) and SFCT (B) across different age cohorts among children within the PNM-stable, PM-stable, PNM-progressive, and PM-progressive groups.
Annual AL growth was negatively correlated with SFCT thickening among the four groups of children with different rates of SER progression (all P < 0.05) (Supplementary Tables S3, S4). Baseline AL was significantly associated with annual SFCT change in the PNM-stable and PNM-progressive groups (both P < 0.05), but not in two subgroups of PM children (both P > 0.05). The increase in SFCT was most prominent in PNM-stable children of the G7 cohort (P < 0.001). Furthermore, compared to children in the G4 cohort, PM-progressive children in G7 also exhibited a lesser decrease in SFCT (P = 0.012). Sex was not a significant impactor on annual SFCT change, except in the PNM-progressive group (P = 0.048). 
Figure 3 shows the mean annual changes in SFCT with regard to axial elongation. In PNM children, SFCT thickened and then thinned, with a turning point in annual axial elongation at approximately 0.20 mm. Similarly, in PM children, SFCT started to thin when annual axial elongation was around 0.18 mm. This observed pattern of choroidal changes with AL elongation aligns with the above results, indicating that the SFCT thinning occurred when AL progressed rapidly. 
Figure 3.
 
Changes in SFCT with AL growth in PNM and PM children. The curves were fitted with LOWESS plots with a span of 0.50.
Figure 3.
 
Changes in SFCT with AL growth in PNM and PM children. The curves were fitted with LOWESS plots with a span of 0.50.
Discussion
In this prospective longitudinal study, we have, for the first time, to the best of our knowledge, shown that changes in SFCT differ, as they increased among the nonmyopic children with stable refraction, remained stable among the myopic children with stable refraction, and decreased in both nonmyopic and myopic children with refractive progression. Many studies have investigated the development of the choroid. Unlike the choroidal thickening observed from birth to puberty in normally reared animals,12 the change in ChT with age in children varies—typically showing an increase in Western studies9,13,23,24 and a decrease in Asian studies.14,25,26 Racial differences in ChT development might exist; for example, Read et al.27 demonstrated a thicker choroid in Australian indigenous children compared to Caucasian children. However, the onset of myopia also plays an important role in the process of choroidal change. In a longitudinal study, Fontaine et al.16 reported that the SFCT increased in nonmyopic eyes but decreased in myopic eyes during a 15-month follow-up. Jin et al.17 found that the central foveal choroid remained unchanged in children maintaining persistent nonmyopia and decreased when children experienced myopic shifts after 1-year follow-up. Xiong et al.19 reported an increase in ChT in nonmyopic shift children 10 to 13 years old, but it remained unchanged in children of other ages. The inconsistencies observed among these studies may be attributed to the varying refractive progressions in children of school age. 
Targeting children with a relatively low myopia rate (21.4%, lower than those previously reported in Chinese studies 2,28) and making fine divisions based on SER progression, we found that the SFCT increased by 4.54 µm/y (mean value of all four cohorts) in nonmyopic children with stable refraction. Hansen et al.24 reported a 5-year cumulative increase of 33 µm in SFCT among children with mean SER around zero. They also found that the increase of SFCT was less pronounced in girls undergoing early sexual maturation. In our study, children exhibited negligible thickening of SFCT in the G4 cohort (9 to 10 years old), followed by more substantial thickening in the G7 cohort (11 to 13 years old) within the PNM-stable group. Additionally, we observed less choroidal thinning in the G7 cohort among PM-progressive children. The observed greater choroidal thickening and less choroidal thinning in the G7 cohort were both more pronounced in boys. Xiong et al.29 reported a lesser ChT thinning in children 11 years of age and older, which they speculated was mediated by pubertal growth spurts. In another longitudinal study, Xiong et al.19 found that the choroidal increase occurred solely in nonmyopic shift children between the ages of 10 and 13 years. There is a possibility that children in different pubertal stages may experience differences in ChT development, but the precise relationship between them requires further examination through longer follow-up studies that include puberty stage evaluations and involve the same sample of participants with similar refractive states. 
With regard to children undergoing refractive progression, the choroid thinned in both nonmyopic (−6.59 µm/y) and myopic (−6.92 µm/y) eyes. Xiong et al.19 reported a choroidal thinning of −4 µm/y in PNM children and −5 µm/y in PM children. However, in their study, children in these two groups were not differentiated based on SER progression. In this study, we also observed a slight, though nonsignificant, increase in SFCT in children with stable myopia. Read et al.9 found that ChT could increase in myopic children when AL progression is slow. Moreover, studies on myopia control have reported SFCT increases when myopia progression is impeded by atropine eye drops and/or orthokeratology.30,31 These outcomes indicate that, at least during the pediatric period, the choroid may remain stable or thicken in myopic eyes showing relatively slow axial eye growth. 
As previously mentioned and confirmed in our study, the rate of AL growth has an important impact on ChT change; however, the extent to which AL growth leads to choroidal thinning remains uncertain. Read et al.9 reported a negative relationship between SFCT change and AL growth. It can be inferred from their graphical representation that the thickening of SFCT disappeared in both nonmyopic and myopic eyes when AL growth reached around 0.20 mm. Jin et al.17 documented a mean AL growth of 0.19 mm in nonmyopic children whose ChT remained unchanged during a 1-year follow-up. In our study, we observed that the SFCT began to decrease when the mean annual increase in AL was approximately 0.20 mm in the PNM group and 0.18 mm in the PM group. Previous proposals suggest that the developmental increase of the choroid serves as compensation to slow axial eye growth during the juvenile period.12 Mutti et al.32 reported an average elongation of AL about 0.1 mm/y in emmetropic children 6 to 14 years old. Additionally, Tideman et al.33 observed an AL growth of 0.19 mm/y in emmetropic children 9 years old. It is plausible that choroidal thinning occurs when AL extends beyond the compensatory adjustment capacity of the choroid. However, the influence of other factors, including age, sex, baseline ocular status, and more, in the progression of ChT thinning driven by fast AL elongation requires further examination and discussion. Furthermore, the rate of AL growth and the variation in ChT serve as primary indicators for assessing the efficacy of myopic treatment. Elucidating their relationship will provide further insights into the effects of current myopic control therapies. 
The current study has the merit of being the first longitudinal examination, to the best of our knowledge, of choroidal changes in children characterized by a refined division based on stable or progressive refractive statuses. These findings have enriched our comprehension of choroidal development during childhood, providing insights that contribute to addressing inconsistencies observed in previous studies. Furthermore, these results could offer valuable information regarding the role of the choroid in myopia control. Nevertheless, several limitations should be acknowledged. First, the study included Chinese children exclusively; thus, further exploration of ethnic variations in ChT changes with different rates of refractive progression is warranted. Second, this study focused on choroidal changes in children 3 to 14 years old. Recent research by Lee et al.34 revealed that the choroid continued to thicken in young adults without myopic progression during the third decade of life. Extended observations covering a wider age range would provide further insights into the continuous evolution of the choroid throughout life. Third, the low prevalence of myopia, which resulted in uneven subgroup distribution, particularly in the PM-stable and PNM-progressive groups, as well as the exclusion of children in the G4 cohort due to poor image quality, may have introduced bias to our observations within these groups. Future endeavors will involve a larger participant pool to delve deeper into SFCT changes within these refractive and age groups. Fourth, the timing of OCT imaging during follow-up was not standardized, as scans were conducted between 10 AM and 4 PM. Additionally, caffeine intake, body mass index, and birth weight were not controlled for in this study. Although we believe caffeine consumption should be limited in Chinese children of our studied age cohorts, and BMI has been reported as not being correlated with choroidal changes,24 these variables require better control in future studies. Fifth, some of the differences we observed were smaller than the interrater repeatability. This further reminds us of the need for tighter control of possible choroid-related influencing factors in future research, as well as more accurate automated measurement in ChT. Finally, in our study, baseline and follow-up SFCT was obtained after achieving complete cycloplegia induced by 1% cyclopentolate hydrochloride. This approach was adopted to optimize image quality and eliminate the potential influence of accommodation on ChT. However, previous reports have indicated that cycloplegic agents can influence ChT.3538 The consistency of choroidal changes measured before and after cycloplegia during longitudinal studies requires further discussion. 
In conclusion, our study revealed that the development of SFCT was influenced by the combination of age and refractive state. Specifically, SFCT increased in nonmyopic children with stable refraction, remained stable in myopic children with stable refraction, and decreased in those suffering rapid refractive progression, irrespective of whether they were myopic or nonmyopic. 
Acknowledgments
Supported by grants from the Science and Technology Planning Project of Guangzhou (202002030405), Medical Scientific Research Foundation of Guangdong Province (A2020146), and National Natural Science Foundation of China (82070995). 
Disclosure: M. Shen, None; X. Han, None; Y. Yang, None; H. Huang, None; J. Hou, None; L. Jin, None; X. Yu, None; Y. Zeng, None; M. He, None 
References
Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016; 123(5): 1036–1042. [CrossRef] [PubMed]
Dong L, Kang Y, Li Y, Wei W, Jonas JB. Prevalence and time trends of myopia in children and adolescents in China: a systemic review and meta-analysis. Retina. 2020; 40(3): 399–411. [CrossRef] [PubMed]
Sankaridurg P, Tahhan N, Kandel H, et al. IMI impact of myopia. Invest Ophthalmol Vis Sci. 2021; 62(5): 2. [CrossRef] [PubMed]
Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res. 2010; 29(2): 144–168. [CrossRef] [PubMed]
Wallman J, Wildsoet C, Xu A, et al. Moving the retina: choroidal modulation of refractive state. Vision Res. 1995; 35(1): 37–50. [CrossRef] [PubMed]
Moderiano D, Do M, Hobbs S, et al. Influence of the time of day on axial length and choroidal thickness changes to hyperopic and myopic defocus in human eyes. Exp Eye Res. 2019; 182: 125–136. [CrossRef] [PubMed]
Chakraborty R, Read SA, Collins MJ. Hyperopic defocus and diurnal changes in human choroid and axial length. Optom Vis Sci. 2013; 90(11): 1187–1198. [CrossRef] [PubMed]
Zhou X, Zhang S, Zhang G, et al. Increased choroidal blood perfusion can inhibit form deprivation myopia in guinea pigs. Invest Ophthalmol Vis Sci. 2020; 61(13): 25. [CrossRef] [PubMed]
Read SA, Alonso-Caneiro D, Vincent SJ, Collins MJ. Longitudinal changes in choroidal thickness and eye growth in childhood. Invest Ophthalmol Vis Sci. 2015; 56(5): 3103–3112. [CrossRef] [PubMed]
Read SA, Collins MJ, Vincent SJ, Alonso-Caneiro D. Choroidal thickness in myopic and nonmyopic children assessed with enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2013; 54(12): 7578–7586. [CrossRef] [PubMed]
Hung LF, Wallman J, Smith EL, 3rd. Vision-dependent changes in the choroidal thickness of macaque monkeys. Invest Ophthalmol Vis Sci. 2000; 41(6): 1259–1269. [PubMed]
Troilo D, Nickla DL, Wildsoet CF. Choroidal thickness changes during altered eye growth and refractive state in a primate. Invest Ophthalmol Vis Sci. 2000; 41(6): 1249–1258. [PubMed]
Read SA, Collins MJ, Vincent SJ, Alonso-Caneiro D. Choroidal thickness in childhood. Invest Ophthalmol Vis Sci. 2013; 54(5): 3586–3593. [CrossRef] [PubMed]
He X, Jin P, Zou H, et al. Choroidal thickness in healthy chinese children aged 6 to 12: the Shanghai Children Eye Study. Retina. 2017; 37(2): 368–375. [CrossRef] [PubMed]
Nagasawa T, Mitamura Y, Katome T, et al. Macular choroidal thickness and volume in healthy pediatric individuals measured by swept-source optical coherence tomography. Invest Ophthalmol Vis Sci. 2013; 54(10): 7068–7074. [CrossRef] [PubMed]
Fontaine M, Gaucher D, Sauer A, Speeg-Schatz C. Choroidal thickness and ametropia in children: a longitudinal study. Eur J Ophthalmol. 2017; 27(6): 730–734. [CrossRef] [PubMed]
Jin P, Zou H, Xu X, et al. Longitudinal changes in choroidal and retinal thicknesses in children with myopic shift. Retina. 2019; 39(6): 1091–1099. [CrossRef] [PubMed]
Xiong S, He X, Zhang B, et al. Changes in choroidal thickness varied by age and refraction in children and adolescents: a 1-year longitudinal study. Am J Ophthalmol. 2020; 213: 46–56. [CrossRef] [PubMed]
Xiong S, He X, Zhang B, et al. Changes in choroidal thickness varied by age and refraction in children and adolescents: a 1-year longitudinal study. Am J Ophthalmol. 2020; 213: 46–56. [CrossRef] [PubMed]
Chen S, Guo Y, Han X, et al. Axial growth driven by physical development and myopia among children: a two year cohort study. J Clin Med. 2022; 11(13): 3642. [CrossRef] [PubMed]
Han X, Xiong R, Jin L, et al. Longitudinal changes in lens thickness and lens power among persistent non-myopic and myopic children. Invest Ophthalmol Vis Sci. 2022; 63(10): 10. [CrossRef] [PubMed]
Xu M, Yu X, Wan M, et al. Two-year longitudinal change in choroidal and retinal thickness in school-aged myopic children: exploratory analysis of clinical trials for myopia progression. Eye Vis (Lond). 2022; 9(1): 5. [CrossRef] [PubMed]
Bidaut-Garnier M, Schwartz C, Puyraveau M, Montard M, Delbosc B, Saleh M. Choroidal thickness measurement in children using optical coherence tomography. Retina. 2014; 34(4): 768–774. [CrossRef] [PubMed]
Hansen MH, Li XQ, Larsen M, et al. Five-year change in choroidal thickness in relation to body development and axial eye elongation: the CCC2000 Eye Study. Invest Ophthalmol Vis Sci. 2019; 60(12): 3930–3936. [CrossRef] [PubMed]
Park KA, Oh SY. Choroidal thickness in healthy children. Retina. 2013; 33(9): 1971–1976. [CrossRef] [PubMed]
Zhang J, Wu J, Chen J, et al. Macular choroidal thickness in children: the Shandong Children Eye Study. Invest Ophthalmol Vis Sci. 2015; 56(13): 7646–7652. [CrossRef] [PubMed]
Read SA, Cox RA, Alonso-Caneiro D, Hopkins S, Wood JM. Choroidal thickness in indigenous Australian children. Transl Vis Sci Technol. 2020; 9(12): 28. [CrossRef] [PubMed]
Wang J, Ying GS, Fu X, et al. Prevalence of myopia and vision impairment in school students in Eastern China. BMC Ophthalmol. 2020; 20(1): 2. [CrossRef] [PubMed]
Xiong F, Tu J, Mao T, Yu L, Lin N, Liao H. Subfoveal choroidal thickness in myopia: an OCT-based study in young Chinese patients. J Ophthalmol. 2020; 2020: 5896016. [CrossRef] [PubMed]
Yam JC, Jiang Y, Lee J, et al. The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the low-concentration atropine for myopia Progression (LAMP) study. Am J Ophthalmol. 2022; 237: 130–138. [CrossRef] [PubMed]
Li Z, Hu Y, Cui D, Long W, He M, Yang X. Change in subfoveal choroidal thickness secondary to orthokeratology and its cessation: a predictor for the change in axial length. Acta Ophthalmol. 2019; 97(3): e454–e459. [PubMed]
Mutti DO, Hayes JR, Mitchell GL, et al. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol Vis Sci. 2007; 48(6): 2510–2519. [CrossRef] [PubMed]
Tideman JWL, Polling JR, Vingerling JR, et al. Axial length growth and the risk of developing myopia in European children. Acta Ophthalmol. 2018; 96(3): 301–309. [CrossRef] [PubMed]
Lee SS, Alonso-Caneiro D, Lingham G, et al. Choroidal thickening during young adulthood and baseline choroidal thickness predicts refractive error change. Invest Ophthalmol Vis Sci. 2022; 63(5): 34. [CrossRef] [PubMed]
Nilsen NG, Gilson SJ, Pedersen HR, Hagen LA, Wildsoet CF, Baraas RC. The effect of topical 1 % atropine on ocular dimensions and diurnal rhythms of the human eye. Vision Res. 2024; 214: 108341.
Kara N, Demircan A, Karatas G, et al. Effects of two commonly used mydriatics on choroidal thickness: direct and crossover effects. J Ocul Pharmacol Ther. 2014; 30(4): 366–370. [CrossRef] [PubMed]
Öner V, Bulut A, Öter K. The effect of topical anti-muscarinic agents on subfoveal choroidal thickness in healthy adults. Eye (Lond). 2016; 30(7): 925–928. [CrossRef] [PubMed]
Yuvacı İ, Pangal E, Yuvacı S, et al. An evaluation of effects of different mydriatics on choroidal thickness by examining anterior chamber parameters: the Scheimpflug Imaging and Enhanced Depth Imaging-OCT study. J Ophthalmol. 2015; 2015: 981274. [CrossRef] [PubMed]
Figure 1.
 
(Left) An example of the HD radial macular scan using the CIRRUS HD-OCT device. (Right) Illustration of choroidal thickness measurement at the fovea; a perpendicular line was drawn from the posterior edge of the retinal pigment epithelium to the choroid–sclera junction using the built-in caliper tool.
Figure 1.
 
(Left) An example of the HD radial macular scan using the CIRRUS HD-OCT device. (Right) Illustration of choroidal thickness measurement at the fovea; a perpendicular line was drawn from the posterior edge of the retinal pigment epithelium to the choroid–sclera junction using the built-in caliper tool.
Figure 2.
 
Mean annual changes in AL (A) and SFCT (B) across different age cohorts among children within the PNM-stable, PM-stable, PNM-progressive, and PM-progressive groups.
Figure 2.
 
Mean annual changes in AL (A) and SFCT (B) across different age cohorts among children within the PNM-stable, PM-stable, PNM-progressive, and PM-progressive groups.
Figure 3.
 
Changes in SFCT with AL growth in PNM and PM children. The curves were fitted with LOWESS plots with a span of 0.50.
Figure 3.
 
Changes in SFCT with AL growth in PNM and PM children. The curves were fitted with LOWESS plots with a span of 0.50.
Table 1.
 
Baseline Characteristics of the Study Participants
Table 1.
 
Baseline Characteristics of the Study Participants
Table 2.
 
Baseline and Follow-Up Characteristics of SER, AL, and SFCT in Three Refractive Groups
Table 2.
 
Baseline and Follow-Up Characteristics of SER, AL, and SFCT in Three Refractive Groups
Table 3.
 
Baseline and Follow-Up Characteristics in SER, AL, and SFCT Among Children With Different Rates of SER Progression
Table 3.
 
Baseline and Follow-Up Characteristics in SER, AL, and SFCT Among Children With Different Rates of SER Progression
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×